title: Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
authors.forename: Luanne M
authors.initials: LM
authors.lastname: Metz
authors.forename: Yunyan
authors.initials: Y
authors.lastname: Zhang
authors.forename: Michael
authors.initials: M
authors.lastname: Yeung
authors.forename: David G
authors.initials: DG
authors.lastname: Patry
authors.forename: Robert B
authors.initials: RB
authors.lastname: Bell
authors.forename: Cristina A
authors.initials: CA
authors.lastname: Stoian
authors.forename: V Wee
authors.initials: VW
authors.lastname: Yong
authors.forename: Scott B
authors.initials: SB
authors.lastname: Patten
authors.forename: Pierre
authors.initials: P
authors.lastname: Duquette
authors.forename: Jack P
authors.initials: JP
authors.lastname: Antel
authors.forename: J Ross
authors.initials: JR
authors.lastname: Mitchell
mesh_terms: D000328:Adult; D005260:Female; D005682:Gadolinium; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008911:Minocycline / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000473:pathology
chemical_list: D005682:Gadolinium; D008911:Minocycline